TOKIO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) ha anunciado hoy que Roche ha obtenido la autorización de comercialización de la Comisión Europea para el anticuerpo monoclonal humanizado contra el receptor de IL-6 de unión dependi…
Author: Business Wire
Samenvatting: Chugai’s Enspryng (Satralizumab) goedgekeurd door de Europese Commissie als eerste subcutane behandeling thuis voor neuromyelitis Optica Spectrum Disorder (NMOSD)
TOKIO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) heeft vandaag aangekondigd dat Roche een vergunning voor het in de handel brengen heeft gekregen van de Europese Commissie voor het pH-afhankelijke bindende gehumaniseerde anti-IL-6-…
Enspryng (Satralizumab) de Chugai approuvé par la Commission européenne en tant que premier traitement sous-cutané à domicile pour le trouble du spectre de la neuromyélite optique (NMOSD)
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO : 4519) a annoncé aujourd’hui que Roche avait obtenu l’autorisation de mise sur le marché de la Commission européenne pour l’anticorps monoclonal humanisé anti-récepteur de l’IL-6 à liaison…
Chugai’s Enspryng (Satralizumab) Approved by European Commission as First At-home Subcutaneous Treatment for Neuromyelitis Optica Spectrum Disorder (NMOSD)
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that Roche has been granted Marketing Authorization from the European Commission for the pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody Enspryn…
Second Sight Medical Products Announces Closing of Public Offering
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individu…
OcuTerra Appoints David J. Tanzer, MD, as Chief Medical Officer
BOSTON–(BUSINESS WIRE)–OcuTerra Therapeutics appoints David J. Tanzer, MD, as Chief Medical Officer and Executive Vice President, Clinical and Medical Affairs
UM School of Medicine Receives Award for Research on Aging and Cognitive Function
MIAMI–(BUSINESS WIRE)–The Dr. M. Lee Pearce Foundation announces funding to UM’s School of Medicine in support of its research on aging and cognitive function.
Santen Receives FDA Approval for Verkazia™ (Cyclosporine Ophthalmic Emulsion) 0.1% for the Treatment of Vernal Keratoconjunctivitis in Children and Adults
EMERYVILLE, Calif.–(BUSINESS WIRE)–The U.S. FDA has approved Santen’s Verkazia™ (cyclosporine ophthalmic emulsion) 0.1% eye drops for the treatment of VKC in children and adults.
FDA Accepts Application for Genentech’s Port Delivery System With Ranibizumab (PDS) for Treatment of Wet Age-Related Macular Degeneration (AMD)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA), under Pr…
Zenni Surpasses 40 Million Pairs of Glasses Sold Across 18 Years of Uncharted Growth
NOVATO, Calif.–(BUSINESS WIRE)–Zenni, the online eyewear retail leader, announced today it has surpassed another industry milestone, selling more than 40 million pairs of frames since its launch in 2003. In 2020 alone, the direct to consumer retail p…
$35.64 Billion Eyewear Markets – Global Forecasts from 2021 to 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyewear Market – Forecasts from 2021 to 2026” report has been added to ResearchAndMarkets.com’s offering. The global eyewear market is evaluated at US$26.031 billion for the year 2019 and is projected to growing at a CAGR …
Smart Eye Completes Acquisition of Affectiva
GOTHENBURG, Sweden & BOSTON–(BUSINESS WIRE)–Smart Eye, the leader in AI-based eye tracking, announced that it has completed its acquisition of Affectiva, the pioneer of Emotion AI and Human Perception AI, per the agreement that was announced on May 2…
EyeQue Teams Up with EyecareLive to Offer Virtual Eye Health Care with Expert Doctors
NEWARK, Calif. & SANTA CLARA, Calif.–(BUSINESS WIRE)– #digitalhealth–EyeQue and EyecareLive partner to help people quickly, safely connect with eye doctors to address immediate eye health concerns.
Second Sight Medical Products Announces Pricing of Public Offering
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individu…
Second Sight Medical Products Announces Proposed Public Offering of Common Stock
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”) a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individua…
Gemini Therapeutics Announces Initial Data From Its Ongoing Phase 2a Study of GEM103 in Patients With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, Inc. (Nasdaq:GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced initial data from i…
Warby Parker Announces Confidential Submission of Draft Registration Statement for Proposed Public Listing
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed public listing of its Class A …
Yukon Supports Ridgemont and Sunvera Group’s Partnership with TruVista Surgery Center
MINNEAPOLIS–(BUSINESS WIRE)– #mezzanine–Yukon supports Sunvera Group in its partnership with TruVista Surgery Center. Sunvera is a portfolio company of Ridgemont Equity Partners.
jCyte Announces Appointment of Dr. Adam Walsh as Chief Financial Officer
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the further expansion of the company’s executive management team with the ap…
Solutionreach Partners with DoctorLogic to Expand Patient Acquisition Capabilities
LEHI, Utah & PLANO, Texas–(BUSINESS WIRE)– #healthsystems–Solutionreach, the leader in patient relationship management software, and DoctorLogic, the premier website marketing and patient acquisition platform, today announce a partnership that expan…